Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6738
-0.0137 (-1.99%)
Apr 21, 2026, 3:14 PM EDT - Market open
Humacyte Market Cap
Humacyte has a market cap or net worth of $149.6 million as of April 21, 2026. Its market cap has decreased by -33.49% in one year.
Market Cap
149.60M
Enterprise Value
166.11M
1-Year Change
-33.49%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $149.60M, an increase of 20.34%. That is a compound annual growth rate of 3.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 152.64M | -17.66% |
| Dec 31, 2025 | 185.37M | -71.47% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 160.19M |
| Agenus | 158.59M |
| Oramed Pharmaceuticals | 158.14M |
| Fate Therapeutics | 158.12M |
| Tiziana Life Sciences | 155.06M |
| Tenaya Therapeutics | 152.55M |
| Connect Biopharma Holdings | 151.76M |
| Alpha Cognition | 150.02M |